DK1005540T3 - IKK-beta-proteiner, nukleinsyrer og fremgangsmåder - Google Patents

IKK-beta-proteiner, nukleinsyrer og fremgangsmåder

Info

Publication number
DK1005540T3
DK1005540T3 DK98933095T DK98933095T DK1005540T3 DK 1005540 T3 DK1005540 T3 DK 1005540T3 DK 98933095 T DK98933095 T DK 98933095T DK 98933095 T DK98933095 T DK 98933095T DK 1005540 T3 DK1005540 T3 DK 1005540T3
Authority
DK
Denmark
Prior art keywords
ikk
beta
nucleic acids
methods
disclosed
Prior art date
Application number
DK98933095T
Other languages
English (en)
Inventor
David V Goeddel
John Woronicz
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Application granted granted Critical
Publication of DK1005540T3 publication Critical patent/DK1005540T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK98933095T 1997-07-01 1998-07-01 IKK-beta-proteiner, nukleinsyrer og fremgangsmåder DK1005540T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88711497A 1997-07-01 1997-07-01
US08/890,853 US5851812A (en) 1997-07-01 1997-07-10 IKK-β proteins, nucleic acids and methods
PCT/US1998/013783 WO1999001542A1 (en) 1997-07-01 1998-07-01 IKK-β PROTEINS, NUCLEIC ACIDS AND METHODS
EP98933095A EP1005540B1 (en) 1997-07-01 1998-07-01 Ikk-beta proteins, nucleic acids and methods

Publications (1)

Publication Number Publication Date
DK1005540T3 true DK1005540T3 (da) 2004-10-18

Family

ID=27128822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98933095T DK1005540T3 (da) 1997-07-01 1998-07-01 IKK-beta-proteiner, nukleinsyrer og fremgangsmåder

Country Status (10)

Country Link
US (3) US5851812A (da)
EP (1) EP1005540B1 (da)
JP (2) JP3472584B2 (da)
AT (1) ATE269402T1 (da)
AU (1) AU725477B2 (da)
CA (1) CA2294516C (da)
DE (1) DE69824597T2 (da)
DK (1) DK1005540T3 (da)
ES (1) ES2218839T3 (da)
WO (1) WO1999001542A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972674A (en) * 1996-08-26 1999-10-26 Signal Pharmaceuticals, Inc. Stimulus-inducible protein kinase complex and methods of use therefor
JP4695735B2 (ja) * 1996-08-26 2011-06-08 シグナル ファーマシューティカルズ， エルエルシー 刺激誘導性Ｉ（κ）Ｂキナーゼ［ＩＫＫ］シグナルソーム
EP0981642A4 (en) * 1997-02-25 2003-03-19 Univ California NF-KAPPA B KAPPA B INHIBITOR KINASE, KAPPA B KINASE SUBUNITS AND METHODS OF USE
US6235512B1 (en) * 1997-07-01 2001-05-22 Tularik Inc. IKK-α proteins, nucleic acids and methods
US6087169A (en) * 1997-08-04 2000-07-11 Smithkline Beecham Plc HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide
EP0897009A3 (en) * 1997-08-04 1999-06-09 Smithkline Beecham Plc HKABY60 polypeptides
US6242253B1 (en) 1997-10-09 2001-06-05 Regents Of The University Of California IkB kinase, subunits thereof, and methods of using same
US6030834A (en) * 1997-12-30 2000-02-29 Chiron Corporation Human IKK-beta DNA constructs and cells
CA2346937A1 (en) * 1998-10-15 2000-04-27 Per O. G. Arkhammar Specific therapeutic interventions obtained by interference with redistribution and/or targeting
ATE499445T1 (de) * 1998-12-10 2011-03-15 Signal Pharm Llc Menschliche ubiqutin ligase e3. verwendung für die modulation von nf-kappa b
UA73492C2 (en) * 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
EP1157026A1 (en) 1999-02-22 2001-11-28 Boehringer Ingelheim Pharmaceuticals Inc. Polycyclo heterocyclic derivatives as antiinflammatory agents
ES2251360T3 (es) 1999-03-12 2006-05-01 Boehringer Ingelheim Pharmaceuticals Inc. Compuestos heterociclicos aromaticos en calidad de agentes antiinflamatorios.
EE04799B1 (et) 1999-03-12 2007-04-16 Boehringer Ingelheim Pharmaceuticals, Inc. Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
ES2253233T3 (es) * 1999-07-09 2006-06-01 Boehringer Ingelheim Pharmaceuticals Inc. Procedimiento para sintesis de compuestos de urea heteroaril sustituidos.
US6468755B1 (en) 1999-08-10 2002-10-22 Joslin Diabetes Center, Inc. Method for identifying compounds for treatment of insulin resistance
US6630312B2 (en) 1999-08-10 2003-10-07 Joslin Diabetes Center, Inc. Method for identifying compounds for treatment of insulin resistance
AU2007202315B2 (en) * 1999-09-30 2009-11-19 Yale University Anti-inflammatory compounds and uses thereof
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
AU3007001A (en) * 1999-12-06 2001-06-12 Axxima Pharmaceuticals Ag Method for identification and quantification of kinase inhibitors
AU2368201A (en) * 1999-12-23 2001-07-09 Xantos Biomedicine Ag Screening method for nucleic acids
US6525046B1 (en) 2000-01-18 2003-02-25 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds as antiinflammatory agents
US6608052B2 (en) 2000-02-16 2003-08-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US7049395B2 (en) 2000-05-02 2006-05-23 Yale University Anti-inflammatory compounds and uses thereof
US20030044852A1 (en) * 2000-08-10 2003-03-06 Joslin Diabetes Center, Inc., A Massachusetts Corporation Methods for treatment of insulin resistance
US6869956B2 (en) * 2000-10-03 2005-03-22 Bristol-Myers Squibb Company Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
CA2436770A1 (en) * 2001-02-01 2002-08-08 James R. Burke Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk)
DE10115073A1 (de) * 2001-03-27 2002-10-10 Procorde Gmbh Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren
WO2002082082A2 (en) * 2001-04-09 2002-10-17 Boehringer Ingelheim Pharmaceuticals, Inc. Fluorescence polarization assay
US20030118578A1 (en) * 2001-11-09 2003-06-26 Anthony Rosenzweig Methods for treating ischemic reperfusion injury using IkappaB kinase-beta inhibitors
US20030118575A1 (en) * 2001-12-11 2003-06-26 Boehringer Ingelheim Pharmaceuticals, Inc. Method for administering BIRB 796 BS
WO2003072569A1 (en) * 2002-02-25 2003-09-04 Boehringer Ingelheim Pharmaceuticals, Inc. 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
WO2005101019A2 (en) * 2004-04-12 2005-10-27 University Of Vermont And State Agricultural College Detection of nitrosylated proteins
EP2001455A2 (en) * 2006-03-15 2008-12-17 Theralogics, Inc. Methods of treating muscular wasting diseases using nf-kb activation inhibitors
WO2007137220A2 (en) 2006-05-22 2007-11-29 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of ikk-b gene
CA2725008C (en) 2008-05-28 2017-09-05 Validus Biopharma, Inc. Non-hormonal steroid modulators of nf-.kappa.b for treatment of disease
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4695735B2 (ja) * 1996-08-26 2011-06-08 シグナル ファーマシューティカルズ， エルエルシー 刺激誘導性Ｉ（κ）Ｂキナーゼ［ＩＫＫ］シグナルソーム
EP0981642A4 (en) * 1997-02-25 2003-03-19 Univ California NF-KAPPA B KAPPA B INHIBITOR KINASE, KAPPA B KINASE SUBUNITS AND METHODS OF USE
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
EP0897009A3 (en) * 1997-08-04 1999-06-09 Smithkline Beecham Plc HKABY60 polypeptides
US6030834A (en) * 1997-12-30 2000-02-29 Chiron Corporation Human IKK-beta DNA constructs and cells

Also Published As

Publication number Publication date
AU8283798A (en) 1999-01-25
US5939302A (en) 1999-08-17
ATE269402T1 (de) 2004-07-15
DE69824597D1 (de) 2004-07-22
JP2003274984A (ja) 2003-09-30
CA2294516C (en) 2003-10-21
CA2294516A1 (en) 1999-01-14
EP1005540A4 (en) 2003-04-02
JP3472584B2 (ja) 2003-12-02
AU725477B2 (en) 2000-10-12
JP2001510347A (ja) 2001-07-31
US5916760A (en) 1999-06-29
EP1005540A1 (en) 2000-06-07
EP1005540B1 (en) 2004-06-16
DE69824597T2 (de) 2005-06-09
ES2218839T3 (es) 2004-11-16
WO1999001542A1 (en) 1999-01-14
US5851812A (en) 1998-12-22

Similar Documents

Publication Publication Date Title
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
WO1999033982A3 (en) Human genes and gene expression products i
BG100771A (en) Hematopoeic protein and ways and methods for its preparation
DE69808743T2 (de) Netrinrezeptoren
ATE374247T1 (de) Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
EP0804609A4 (en) NEW GENES OF RESPONSE p53
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
WO1996015144A3 (en) Chromosome 21 gene marker, compositions and methods using same
ATE356137T1 (de) Neue moleküle aus der familie der tango-77- ähnlichen proteine und ihre verewendungen.
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
CA2281895A1 (en) Ikb kinases
WO2000052047A3 (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
ATE245190T1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
MXPA02008239A (es) Gen humano de la esquizofrenia.
WO2001014420A3 (en) Novel members of the plexin family and uses thereof
WO1998006841A3 (en) Two human nsp-like proteins
CA2294476A1 (en) Semaphorin receptors
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO2000019988A8 (en) NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
WO1998011234A3 (en) Human protein kinases
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
WO2001036478A3 (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
WO2001000662A3 (en) The use of human fgh-8 polypeptides as neurotrophic agents